Disruptive Endovascular Technology with Multilayer Flow Modulator Stents (MFM) as a Therapeutic Option in the Management of Thoraco-abdominal Aortic Aneurysms. Early results from MFM Registry.

Research output: Other contribution (Published)Other contribution

Original languageEnglish (Ireland)
Media of outputAbstract
Volume60
Publication statusPublished - 1 Oct 2012

Cite this